TABLE 2.
ken | ksort |
kfuseE |
kseq |
kfuseG |
||||
---|---|---|---|---|---|---|---|---|
Basal | Insulin | Basal | Insulin | Basal | Insulin | |||
Three-step: Δkfuse | ||||||||
3T3-L1 fibroblasts, free fita | 0.18 | 0.053 | 0.033 | 0.080 | ||||
3T3-L1 adipocytes, free fita | 0.11 | 0.350 | 0.001 | 0.027 | ||||
AS160 KD adipocytes, free fita | 0.12 | 0.055 | 0.006 | 0.032 | ||||
Dynamic retention: two exocytic pathways, GSV and ERC | ||||||||
3T3-L1 adipocytes, constrained fita | 0.12 | 0.042 | 0.025 | 0.088 | 0.021 | 0.059 | 0.0007 | 0.025 |
Primary adipocytes, calculatedb | 0.05 | 0.013 | 0.018 | 0.078 | 0.006 | 0.143 | 0.0005 | 0.05 |
3T3-L1 adipocytes, alternate fitc | 0.11 | 0.013 | 0.018 | 0.078 | 0.006 | 0.143 | 0.0006 | 0.028 |
AS160 KD adipocytes, alternate fitc | 0.12 | 0.013 | 0.018 | 0.078 | 0.018 | 0.030 | 0.005 | 0.028 |
a Determined from free fits or constrained fits (ksort and kfuseE from fibroblasts) of the kinetics data.
b Calculated from the steady state distributions using Equations 1–3.
c Determined from constrained fits using ksort, kfuseE, and kseq from primary adipocytes instead of fibroblasts. For AS160 KD, kseq was estimated from LRP1 surface data (Table 3) as described.